Corvus Pharmaceuticals Inc (CRVS)

Operating Expenses

$19.30M

Quarterly · Period ending: · USD

CRVS logo

CRVS Operating Expenses

Latest reported$19.30M
CRVS Quarterly Operating Expenses ($153.64K → $19.30M)
High-resolution chart · PNG

CRVS operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Corvus Pharmaceuticals Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
19,297,000
14,877,000
12,191,000
10,572,000
10,260,000
9,922,000
8,105,000
7,255,000
5,935,000
6,253,000
5,651,000
5,560,000
5,622,000
6,574,000
5,666,000
12,473,000
7,013,000
7,413,000
6,810,000
9,047,000
11,290,000
11,483,000
9,879,000
9,845,000
10,767,000
13,269,000
11,440,000
11,513,000
13,596,000
12,305,000
11,171,000
11,149,000
12,258,000
14,644,000
12,189,000
12,944,000
15,174,000
16,217,000
11,249,000
10,476,000
8,825,000
6,426,000
6,104,000
3,120,000
2,332,000
2,214,000
153,636
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.